Ms  Myfanwy Graham

Ms Myfanwy Graham

Associate Lecturer

School of Medicine and Public Health (Pharmacy and Experimental Pharmacology)

ACRE researcher awarded prestigious Fulbright scholarship

  • Myfanwy Graham will head to the U.S. in 2022 to undertake a binational comparison of medicinal cannabis policy and patient outcomes.
  • Awardees take part in an academic and cultural exchange, pursuing research or study at a U.S. institution, experiencing life abroad and bringing back their knowledge and experience to share with their communities in Australia.
  • Established in 1945, a Fulbright award is more than a scholarship – it is, in the words of Senator Fulbright, a means of fostering “leadership, learning, and empathy between cultures… It is a modest program with an immodest aim – the achievement in international affairs of a regime more civilised, rational and humane than the empty system of power of the past.”

A pharmacist is the latest recipient of the prestigious Fulbright Scholarship and the first in her field to be awarded the opportunity.

Myfanwy Graham is a Research Associate with the Australian Centre for Cannabinoid Clinical and Research Excellence (ACRE).

A smiling woman with blonde hair looking into the camera

Professor Jennifer Martin, Director of ACRE, said this influential opportunity puts Ms Graham’s career on an entirely new trajectory.

“The Fulbright Scholarship is held in high esteem by international researchers,” Professor Martin said.

“Myf is the first Australian in her field to be awarded this opportunity. We are immensely proud to see an Australian health researcher recognised by her international peers and, of course, proud that she is part of the team at ACRE and the University of Newcastle.”

For Ms Graham, the award is a significant achievement, consolidating years of work to implement ‘real-world projects’ that draw together leading researchers and showcase Australia’s research achievements.

“Building mutual research linkages between Australia and the United States helps to bring together leading researchers in this space and helps us deliver research results into clinical practice,” Ms Graham said.

“Our research looks at patient outcomes, current clinical practice, and policies and regulations in the U.S. and Australia. Strong research collaborations in the space have the potential to produce important change - not just clinically, but more broadly as well. When you have brilliant researchers working around the world, the impact of bringing them together can be immense.

“I want to help draw together the communities of researchers around the world to consolidate the dedicated work we all do and build on it so we can learn and share knowledge because, at the heart of it, it all comes back to the patient and the hope that translating this research can help patients and their families.”

In heading to the US in 2022, Ms Graham is retracing her mother’s footsteps.

“'As a child, I lived and attended school in the US for a year while my mother was working as an exchange teacher. It was then that I developed a life-long love of meeting people from different cultural backgrounds and this is a large part of why I am drawn to collaborative research in the US,” she said.

“A significant part of the Fulbright scholarship is the cultural ambassador component so my family will also have the opportunity to be immersed in a different culture and take on an ambassadorial role for Australia.”

Ms Graham will be heading to Los Angeles in 2022 and working with Professor Rosalie Pacula, the Elizabeth Garrett Chair in Health Policy, Economics Law in the Sol Price School of Public Policy, and the Leonard D. Schaeffer Center for Health Policy Economics at the University of Southern California (USC).

A smiling woman with blonde hair looking into the camera

ACRE researcher awarded prestigious Fulbright scholarship

Myfanwy Graham is Principal Specialist Medicines Information Pharmacist for the NSW Cannabis Medicines Advisory Service and researcher with the Australian Centre for Cannabinoid Clinical and Research Excellence (ACRE).

Read more

Career Summary

Biography

Collaborative research with impact

Myfanwy is an associate investigator with the Australian Centre for Cannabinoid Clinical and Research Excellence (ACRE) a NHMRC Centre of Research Excellence. Myfanwy has collaboratively developed several medicinal cannabis research projects and contributed to a suite of NSW cannabis medicine prescribing guidance documents.

Myfanwy's research interests include medicinal cannabis, medical and allied health professional education, pharmacovigilance, and personalised medicine.  

Clinical role - Knowledge translation

Myfanwy was the principal specialist medicines information pharmacist of the New South Wales Cannabis Medicines Advisory Service (CMAS) that operated between 2018 and mid-2022, a first of kind in the world, Australian State government-funded cannabis medicines advisory service for health professionals. The service model, led by a clinical pharmacologist and pharmacist, provided comprehensive patient-specific and evidence-based information to support health professionals in prescribing and patient-care decisions. Under this leadership, the service delivered sustained, exceptional outcomes and gained national and international recognition. Myfanwy has collaboratively developed and provided subject matter expert review of national medicinal cannabis educational resources and state prescribing guidance documents.

Multidisciplinary teaching experience

Myfanwy has worked in multi-disciplinary health professional training and education since 2009.  Myfanwy primarily teaches into the Joint Medical Program in the areas of Problem Based Learning and Clinical Skills. Myfanwy also delivers pharmacology lectures in allied health degrees.


Qualifications

  • Master of Pharmacy, University of Newcastle

Keywords

  • cannabinoids
  • cannabis medicines
  • health professional education
  • personalised medicine
  • pharmacology
  • pharmacovigilance

Fields of Research

Code Description Percentage
321403 Clinical pharmacy and pharmacy practice 20
321402 Clinical pharmacology and therapeutics 60
321406 Pharmacogenomics 20

Professional Experience

UON Appointment

Title Organisation / Department
Associate Lecturer University of Newcastle
School of Medicine and Public Health
Australia
Casual Lecturer University of Newcastle
School of Biomedical Sciences and Pharmacy
Australia

Academic appointment

Dates Title Organisation / Department
1/1/2022 -  Research Associate Australian Centre for Cannabinoid Clinical and Research Excellence
Australia

Membership

Dates Title Organisation / Department
1/1/2006 -  Member - Pharmaceutical Society of Australia Pharmaceutical Society of Australia
Australia

Teaching appointment

Dates Title Organisation / Department
31/7/2018 -  Associate Lecturer in Medical Education School of Medicine & Public Health, Faculty of Health & Medicine, University of Newcastle | Australia
Australia
1/1/2017 - 31/12/2021 Sessional Academic The University of Newcastle - School of Biomedical Sciences and Pharmacy
Australia
31/3/2009 - 31/12/2016 Associate Lecturer School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle
Australia

Awards

Prize

Year Award
2006 Faculty of Health Medal
Faculty of Health and Medicine, University of Newcastle
2004 Academic Achievement Award
Southern Cross University

Professional

Year Award
2020 NSW Regional Health Partners Knowledge Translation Fellowship
NSW Regional Health Partners
2020 Faculty of Health and Medicine ThinkWell EMCR Development Program for 2020
University of Newcastle

Research Award

Year Award
2021 SMPH ECR/MCR Best New Project Award
University of Newcastle

Scholarship

Year Award
2021 Fulbright NSW Postgraduate Scholarship
Australian-American Fulbright Association
2000 Vice Chancellor's Scholarship
Southern Cross University

Invitations

Interviewee

Year Title / Rationale
2021 Medicinal cannabis research - ABC Radio Newcastle

Panel Participant

Year Title / Rationale
2022 RSMj 6th Annual Meeting
2020 ACRE Annual Scientific Meeting Panel Participant
2019 The 2nd International Annual Congress on Controversies on Cannabis-Based Medicines

Speaker

Year Title / Rationale
2022 The 3rd International Annual Congress on Controversies on Cannabis-Based Medicines
2021 ConPharm 2021 17th Annual Consultant Clinical Pharmacy Seminar
2021 Renal Society of Australasia 2021 Annual Conference
2018 National Directors of Pharmacy Forum
Edit

Publications

For publications that are currently unpublished or in-press, details are shown in italics.


Journal article (18 outputs)

Year Citation Altmetrics Link
2024 Dobson O, Barber M, Graham M, Carter A, Savic M, ''The wild west of medicine': A qualitative investigation of the factors influencing Australian health-care practitioners' delivery of medicinal cannabis', DRUG AND ALCOHOL REVIEW, [C1]
DOI 10.1111/dar.13847
2023 Graham M, Chiu V, Stjepanovic D, Hall W, 'A provisional evaluation of Australia's medical cannabis program', International Journal of Drug Policy, 122 (2023) [C1]

In 2016, the Australian Government legislated to allow cannabis to be prescribed to patients as an unapproved medicine under the special access provisions of the Therapeutic Goods... [more]

In 2016, the Australian Government legislated to allow cannabis to be prescribed to patients as an unapproved medicine under the special access provisions of the Therapeutic Goods Act. This paper compares the Australian regulatory approach with other national approaches, outlines the main provisions of the Special Access Scheme for medical cannabis, describes how the program has evolved since 2017, includes an analysis of adverse events reported to the Therapeutic Goods Administration, and discusses the barriers that remain for patients who wish to access medical cannabis. It assesses how well the Australian program has addressed the challenges of providing patients with easier access to medical cannabis while ensuring that high-quality products are used safely and effectively under medical guidance.

DOI 10.1016/j.drugpo.2023.104210
Citations Scopus - 2
2023 Carter A, Graham M, Hall W, Barber M, Gardner J, 'Avoiding the Premature Introduction of Psychedelic Medicines in Alzheimer s Disease and Related Disorders', AJOB Neuroscience, 14 129-131 (2023)
DOI 10.1080/21507740.2023.2188287
2023 Graham M, Renaud E, Lucas CJ, Schneider J, Martin JH, 'Medicinal Cannabis Guidance and Resources for Health Professionals to Inform Clinical Decision Making.', Clin Ther, 45 527-534 (2023) [C1]
DOI 10.1016/j.clinthera.2023.03.007
Citations Scopus - 2Web of Science - 1
Co-authors Catherine Lucas, Jennifer Schneider, Jenniferh Martin
2022 Hallinan CM, Eden E, Graham M, Greenwood L-M, Mills J, Popat A, et al., 'Over the counter low-dose cannabidiol: A viewpoint from the ACRE Capacity Building Group', JOURNAL OF PSYCHOPHARMACOLOGY, 36 661-665 (2022) [C1]
DOI 10.1177/02698811211035394
Citations Scopus - 5Web of Science - 5
Co-authors Linda Truong Uon
2022 Graham M, Martin JH, Lucas CJ, Murnion B, Schneider J, 'Cannabidiol drug interaction considerations for prescribers and pharmacists', EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 15 1383-1397 (2022) [C1]
DOI 10.1080/17512433.2022.2142114
Citations Scopus - 10Web of Science - 1
Co-authors Jennifer Schneider, Catherine Lucas, Jenniferh Martin
2022 Graham M, Bird S, Howard Z, Dobson M, Palazzi K, Lucas CJ, et al., 'NSW Cannabis Medicines Advisory Service preliminary survey results: enquirer perceptions and patient outcomes.', Intern Med J, 52 228-237 (2022) [C1]
DOI 10.1111/imj.15635
Citations Scopus - 5Web of Science - 3
Co-authors Catherine Lucas, Jennifer Schneider, Jenniferh Martin
2022 Lawson J, O'Brien T, Graham M, Renaud E, Jones D, Freeman J, et al., 'Expert advice for prescribing cannabis medicines for patients with epilepsy-drawn from the Australian clinical experience', BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 88 3101-3113 (2022) [C1]
DOI 10.1111/bcp.15262
Citations Scopus - 7Web of Science - 7
Co-authors Jenniferh Martin
2022 Nielsen S, Picco L, Murnion B, Winters B, Matheson J, Graham M, et al., 'Opioid-sparing effect of cannabinoids for analgesia: an updated systematic review and meta-analysis of preclinical and clinical studies', NEUROPSYCHOPHARMACOLOGY, 47 1315-1330 (2022) [C1]
DOI 10.1038/s41386-022-01322-4
Citations Scopus - 27Web of Science - 17
2022 Erku D, Greenwood L-M, Graham M, Hallinan CM, Bartschi JG, Renaud E, Scuffham P, 'From growers to patients: Multi-stakeholder views on the use of, and access to medicinal cannabis in Australia', PLOS ONE, 17 (2022) [C1]
DOI 10.1371/journal.pone.0277355
Citations Scopus - 2
2020 Graham M, Lucas CJ, Schneider J, Martin JH, Hall W, 'Translational hurdles with cannabis medicines', PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 29 1325-1330 (2020)
DOI 10.1002/pds.4999
Citations Scopus - 15Web of Science - 7
Co-authors Catherine Lucas, Jennifer Schneider, Jenniferh Martin
2015 Graham M, Daneshi N, Rasiah RL, Heidari M, milward, 'Personalised medicine: The mother-infant pharmacogenomics of codeine', Australian Pharmacist, 34 62-66 (2015)
Co-authors Liz Milward
2015 Daneshi N, Graham ME, Milward ADRIENNEELIZABETHLIZ, 'An update on warfarin pharmacogenomics Part 1 of 2', Australian Pharmacist, 34 52-56 (2015) [C2]
Co-authors Liz Milward
2015 Graham ME, Milward ADRIENNEELIZABETHLIZ, 'Pharmacogenomics, personalised healthcare and herbal medicine - a paradoxical combination?', Australian Pharmacist, (2015) [C3]
Co-authors Liz Milward
2015 Daneshi N, Graham ME, Biswas M, Milward AE, 'Gene Scene - Health's New Frontier', Australian Pharmacist, (2015) [C2]
Co-authors Liz Milward
2015 Milward AE, Daneshi N, Graham M, 'An update on warfarin pharmacogenomics - part 2', Australian Pharmacist, (2015)
Co-authors Liz Milward
2014 Graham M, Milward AE, 'The future of personalised healthcare in pharmacy practice', Australian Pharmacist, (2014)
Co-authors Liz Milward
2014 Shahandeh A, Purushothuman S, Martin K, Graham M, Johnstone DM, Milward EA, 'Anti-oxidant Phytochemicals As Potential Treatments For Age-Related Macular Degeneration.', Journal of Antioxidant Activity, 1 29-41 (2014)
DOI 10.14302/issn.2471-2140.jaa-14-616
Co-authors Liz Milward, Daniel Johnstone
Show 15 more journal articles

Conference (5 outputs)

Year Citation Altmetrics Link
2019 Graham M, Lucas C, Schneider J, Fizzell J, Brett J, Martin JH, 'Cannabis medicines - Absolutely Safe?', Medical Cannabis and Cannabinoids, Barcelona, Spain (2019)
DOI 10.1159/000500623
Co-authors Catherine Lucas, Jenniferh Martin, Jennifer Schneider
2019 Graham M, Lucas C, Galettis R, Martin J, 'Cannabis and Palliative Care Trials and Tribulations - on behalf of CARE NSW Investigators', London (2019)
Co-authors Jenniferh Martin, Catherine Lucas
2019 Graham M, Williams A, Lucas C, Martin J, 'NSW Cannabis Medicine Advisory Service (CMAS) methodology and evolution', Queenstown, New Zealand (2019)
Co-authors Catherine Lucas, Jenniferh Martin
2018 Lucas C, Schneider J, Renaud E, Fizzell J, Graham M, Cootes A, et al., 'Setting up the world's first drug information/medical advisory service for cannabinoid use for symptom control.', Brisbane (2018)
Co-authors Jennifer Schneider, Catherine Lucas, Jenniferh Martin
2015 Daneshi N, Graham M, Holliday E, Schneider J, Kerr KP, Rasiah R, et al., 'Clinically actionable pharmacogenomic variants in community-dwelling older Australians.', ASMR XXIII NSW Scientific Meeting: Programme and Abstracts, Sydney (2015) [E3]
Co-authors Liz Holliday, Liz Milward, Jennifer Schneider, Rodney Scott, John Attia
Show 2 more conferences
Edit

Ms Myfanwy Graham

Positions

Associate Lecturer
School of Medicine and Public Health
College of Health, Medicine and Wellbeing

Casual Lecturer
School of Biomedical Sciences and Pharmacy
College of Health, Medicine and Wellbeing

Focus area

Pharmacy and Experimental Pharmacology

Contact Details

Email myfanwy.graham@newcastle.edu.au

Office

Location Callaghan
University Drive
Callaghan, NSW 2308
Australia
Edit